Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2025-03-13 00:00:00 ET · period of report 2025-03-13 · accession 0000950170-25-038750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-03-13 | 2025-03-13 | DYN | Friedl-Naderer Johanna | Chief Commercial Off | S - Sale | $12.12 | -143 | 96.1K | -0.1% | -$1,733 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-13 | S | D | 143 | $12.12 | 96,057 | D | — | — | (F2) Includes 93,838 unvested RSUs. |